Locate Gainesville buprenorphine and suboxone doctors who specialize in the treatment of opioid addiction.
|
Eftim Adhami, M.D.
Lupus Foundation of Gainesville
720 SW, 2nd Avenue, Suite 205
Gainesville, FL 32601
Main Tel: (352) 275-8171
|
|
David E. Kemp, M.D.
1026 SW 2nd Avenue
Suite E
Gainesville, FL 32601
Main Tel: (352) 379-1049
|
|
Frank Nathan Anthony, M.D.
Gainesville Psy. and Forensic Services
1026 SW Second Avenue, Suite C
Gainesville, FL 32601
Main Tel: (352) 378-9116
|
|
Dr. Peter M. Gallogly, M.D.
Gainesville After Hours
926 NW 13 Street
Gainesville, FL 32601
Main Tel: (352) 379-1049
|
|
Lawrence O. Adu, M.D.
1103 SW 2nd Avenue
Gainesville, FL 32601
Main Tel: (352) 378-9116
|
|
Dr. Thomas John Raulerson, M.D.
926 NW 13th Street
Gainesville, FL 32601
Main Tel: (352) 379-1049
|
|
|
|
Dr. Danielle Susanne Nelson, M.D.
1707 N Main St
Gainesville, FL 32609
Main Tel: 352-265-9593
|
|
Dr. Wayne Lewis Creelman, M.D.
UF Dept OF Psychiatry
100 Newell Drive, Unit L4-100
Gainesville, FL 32610
Main Tel: (772) 794-0179
|
|
Dr. Leonardo Rodriguez, M.D.
1601 SW Archer Road
Gainesville, FL 32608
Main Tel: (352) 376-1611×6089
|
|
Dr. Robert Blair Sammel,
Gainesville VA Medical Center (11c)
1601 SW Archer Road
Gainesville, FL 32608
Main Tel: (352) 376-1611
|
|
Dr. James Cozby Byrd, III, M.D.
VA Medical Center
1601 SW Archer Road
Gainesville, FL 32608
Main Tel: (352) 374-6014
|
|
Dr. May Eliza Montrichard, M.D.
1216 North West 22nd Avenue
Gainesville, FL 32609
Main Tel: (352) 378-7978
|
|
Scott Teitelbaum, M.D.
Univ of Florida, Dept of Psychiatry
4001 SW 13th Street
Gainesville, FL 32608
Main Tel: (352) 265-5549
|
|
Jamie Smolen, M.D.
University of Florida Dept of Psychiatry
4001 SW 13th Street
Gainesville, FL 32608
Main Tel: (352) 265-5500
|
|
Dr. Anthony Russell, M.D.
4001 Sw 13th Street
Gainesville, FL 32608
Main Tel: (336) 491-0285
|
|
Tonia Lara Werner, MD
4300 SW 13th Street
Gainesville, FL 32608
Main Tel:
|
|
|
|
Dr. Matthew Richard Odom, M.D.
1026 SW 2nd Avenue
Suite A
Gainesville, FL 32601
Main Tel: (352) 379-1049
|
|
Dr. John Howard Abernethy, III
4300 SW 13th Street
Gainesville, FL 32601
Main Tel: (352) 374-5600×8207
|
|
Dr. John A. Bailey, M.D.
4343 West Newberry Road
Suite 6
Gainesville, FL 32607
Main Tel: (352) 224-1813
|
|
Dr. Ashraf Oloufa,
3726 NW 39th Place
Gainesville, FL 32606
Main Tel: (352) 371-6415
|
|
Dr. Alexander Fariborzian, M.D.
1200 NE 55th Boulevard
Gainesville, FL 32641
Main Tel: (352) 375-8484
|
|
Elias H. Sarkis, M.D.
Sarkis Clinical Trials
611 NW 60th Street, Suite C
Gainesville, FL 32607
Main Tel: (352) 333-0094
|
Sublocade Now Available
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for Suboxone. Sublocade is a once monthly injection of time-released buprenorphine typically provided to patients who have been receiving buprenorphine for at least (7) days and who are stable on their medication. The injection Read More
Ohio Increases Buprenorphine Access
In 2017, Ohio increased its number of buprenorphine-approved prescribers by 266. This was the result of a $2.3 million dollar Federal grant that provided state-wide training to doctors, nurse practitioners, and physician assistants as reported by Cleveland.com. Historically, Ohio had numerous communities that were underserved with 19 counties having no buprenorphine providers at the beginning Read More
The Drug Treatment Act of 2000 permitted doctors who meet certain training qualifications to prescribe buprenorphine in the treatment of heroin addiction and other opioid addictions. Buprenorphine physicians became able to assist opioid addicted patients in an office setting bypassing the restrictions that typically apply to patients receiving methadone. This treatment method maximized patient convenience and accessibility thus increasing the number of people who could access medication-assisted treatment (MAT) for opioid addiction.
Sublocade is a newly released medication alternative for treating opioid addiction. It is a product of Indivior, the pharmaceutical company responsible for